The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors

Project: Research

Project Details

Status	Active
Effective start/end date	1/09/15 → …

Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
André, M. P. E., Carde, P., Viviani, S., Bellei, M., Fortpied, C., Hutchings, M., Gianni, A. M., Brice, P., Casasnovas, O., Gobbi, P. G., Zinzani, P. L., Dupuis, J., Iannitto, E., Rambaldi, A., Brière, J., Clément-Filliatre, L., Heczko, M., Valagussa, P., Douxfils, J., Depaus, J. & 2 others, Federico, M. & Mounier, N., 1 Sep 2020, In: Cancer medicine. 9, 18, p. 6565-6575 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Downloads (Pure)
Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
Haguet, H., Graux, C., Mullier, F., Dogné, J-M. & Douxfils, J., 15 May 2020, In: Cancers. 12, 5, 15 p., 1242.
Research output: Contribution to journal › Article › peer-review

File
An updated meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia
Haguet, H., Mullier, F., Graux, C., Dogne, J-M. & Douxfils, J., 13 Jun 2019.
Research output: Contribution to conference › Poster › peer-review

Prix Léo Pharma Cancer & Thrombosis
Haguet, Helene (Recipient), Douxfils, Jonathan (Recipient), MULLIER, Francois (Recipient) & DOGNE, Jean-Michel (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)